Last updated 2026-07-26
- Raised $40M Series A led by Morningside Venture Investments, Oct 2021
- Raised $6M Seed round led by TLV Partners, Jul 2019
Total raised
$46.0M
Last: Undisclosed Round 2021-11
Stage
Series A
Founded
2018
Headcount
49
HQ
Boston, United States
Sector
Health Tech & Life Sciences
About
DeepCure is a biotech company that discovers transformative small molecule therapies for immune and inflammatory diseases. The company utilizes a chemistry platform that integrates AI, physics-based tools, and automated chemical synthesis to identify novel molecules. DeepCure's platform leverages deep learning algorithms, cloud computing, and a proprietary chemistry database to accelerate the creation of novel small molecule therapies.
Funding history · 2 rounds · $46.0M total
2021-10
A Round
$40.0M
★ Morningside Venture InvestmentsTLV PartnersSapir Venture Partners
2019-07
Seed
$6.0M
★ TLV Partners★ Sapir Venture Partners
Headcount over time
From 2 (2019-04) to 31 (2025-12) · +29 (+1450%) · 48 points · source: Finder history + radar grounding
Q&A
- What is DeepCure's primary focus?
- DeepCure is an AI-driven drug discovery company that develops novel small molecule therapeutics for immune and inflammatory diseases.
- What is DeepCure's total funding to date?
- DeepCure has raised a total of $71.4 million USD.
- When did DeepCure close its most recent funding round and who led it?
- In April 2024, DeepCure closed an A Round of $24.6 million USD, led by IAG Capital Partners.
- Who are the co-founders of DeepCure?
- The co-founders of DeepCure are Kfir Schreiber (CEO), Joseph Jacobson, and Thrasyvoulos Karydis (CTO).
- What is the core technology behind DeepCure's drug discovery platform?
- DeepCure utilizes a chemistry platform that integrates AI, physics-based tools, and automated chemical synthesis to identify novel molecules, leveraging deep learning algorithms, cloud computing, and a proprietary chemistry database.
- What was a significant collaboration announced by DeepCure in January 2023?
- In January 2023, DeepCure collaborated with Biosero to establish a fully automated, AI-powered chemistry synthesis platform.
Team · 3
Kfir Schreiber
Founder · CEO & Co-Founder
Joseph Jacobson
Founder · Co-Founder
Thrasyvoulos Karydis
Founder · CTO & Co-Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Artificial IntelligenceDeep Learning
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals
Business model
B2B
Tags
drug-developmentdrug-discoverybiotechnologypharmaceuticalsartificial-intelligencedeep-learning
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | deepcure.com |
|---|---|
| linkedin.com/company/18557550 |
Identifiers & details
| Founded | 2018 |
|---|---|
| Employees (exact) | 49 |
| Offices | Boston |
Radar intelligence
Patents
| EPO | 25 |
|---|
Web history (Wayback)
| Domain | deepcure.com |
|---|
Certificate / subdomain footprint
| Subdomains | 7 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516567518 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2022-02-22 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | ליפסקי לואי 9 תל אביב - יפו |